Raising Health

The Consolidated Drug Channel and Cash-Pay Drugs with Adam Fein

Adam Fein, Olivia Webb, and Julie Yoo

Posted November 3, 2022

Note: This episode was recorded as part of the Bio Eats World podcast, now known as Raising Health.

What’s up with the drug channel? Julie Yoo, a general partner at a16z Bio + Health, joins Adam Fein, the CEO of Drug Channels Institute, and Olivia Webb, the editorial lead for a16z Bio + Health, to discuss this question. We talk about PBMs, the 340B drug program, some of the startups working within and around the primary drug channel, and whether there’s room for entrepreneurs to build in such a consolidated space.

More About This Podcast

Biology and the state of healthcare are undergoing radical shifts.
Raising Health delves into dialogues with scientists, technologists, founders, builders, leaders, and visionaries as they explore how AI, engineering, and technology elevate health to new heights and create a system of enduring health for all.

Learn More